SAURFAR IVS: Financial statements 2019
CVR: 35648534
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
SAURFAR IVS (CVR 35648534) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 33,000 and a net result of DKK -3,223 compared with DKK -555 the year before. That is an increase of 22.6% compared with the year before. The profit margin was -9.8%. Equity in the 2019 report amounted to DKK -261,131.
- Revenue
- DKK 33,000
- Gross Profit
- DKK -3,217
- Profit/Loss
- DKK -3,223
- Equity
- DKK -261,131
- Total Assets
- DKK 163,092
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 33 t. | -3 t. | -3 t. | -261 t. | - |
| 2018 | 27 t. | -555 | -555 | -258 t. | - |
| 2017 | 135 t. | -43 t. | -47 t. | -257 t. | - |
| 2016 | - | -89 t. | -89 t. | -210 t. | - |
| 2015 | - | -74 t. | -74 t. | -121 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
SAURFAR IVS has published its annual report for 2018. Revenue came to DKK 26,927, and the net result was DKK -555.
About SAURFAR IVS
SAURFAR IVS was a Danish company of the type Iværksætterselskab based in Lundby, founded in 2014. The company has been dissolved on 13 October 2021. The company was registered under the industry Detailhandel med andre varer i.a.n. via internet. The company was previously named QASHFLOW IVS and PROFEKTA IVS. In 2019, the company reported revenue of DKK 33,000 and a net result of DKK -3,223 compared with DKK -555 the year before. Equity in the 2019 report amounted to DKK -261,131.